Abstract
We examined the inhibitory effects of novel triterpene glycoside compounds [ziyu-glycoside II (ZY-II) and its methyl ester (ZYM-201)], which originated from the roots of Sanguisorba officinalis L. (Rosaceae), on tissue factor (TF) activity and tumor necrosis factor (TNF)-α production. In in vitro TF activity tests, ZY-II but not ZYM-201 strongly blocked lung TF activity with an IC50 value of 0.46 μM. By contrast, only ZYM-201 dose-dependently inhibited in vivo TF activity with an ED50 value of 1.7 mg/kg, when orally administered. Furthermore, ZYM-201 diminished both in vitro and in vivo TNF-α production with IC50 or ED50 values of 69.4 μM and 87.4 mg/kg, respectively. Therefore, these results suggest either that ZYM-201 may be developed as a potent inhibitor of both TF- and TNF-α-mediated diseases such as atherosclerosis and septic shock, or it may be a lead compound to be derivatized for further improvement of its curative efficacy.
Key words
Sanguisorba officinalis L. - Rosaceae - ziyu-glycosides - ZYM-201 - tissue factor - TNF-α
References
-
1
Broze GJ J r.
Tissue factor pathway inhibitor.
Thromb Haemost.
1995;
74
90-3
-
2
Kim I, Oh J L, Ryu Y S, So J N, Sessa W C, Walsh K. et al .
Angiopoietin negatively regulates expression and activity of tissue factor in endothelial cells.
FASEB J.
2002;
16
126-8
-
3
Rao L V, Rapaport S I.
Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
Proc Natl Acad Sci USA.
1988;
85
6687-91
-
4
Hurlimann D, Enseleit F, Ruschitzka F.
Rheumatoid arthritis, inflammation, and atherosclerosis.
Herz.
2004;
29
760-8
-
5
Dang O, Navarro L, David M.
Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes.
Shock.
2004;
21
470-5
-
6
Chu A J, Walton M A, Prasad J K, Seto A.
Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytic tissue factor activation is mediated by the depressed receptor expression in THP-1 cells.
J Surg Res.
1999;
87
217-24
-
7
Goun E A, Petrichenko V M, Solodnikov S U, Suhinina T V, Kline M A, Cunningham G. et al .
Anticancer and antithrombin activity of Russian plants.
J Ethnopharmacol.
2002;
81
337-42
-
8
Liu X, Cui Y, Yu Q, Yu B.
Triterpenoids from Sanguisorba officinalis
.
Phytochemistry.
2005;
66
1671-9
-
9
Lee M H, Han Y N.
A new in vitro tissue factor inhibitory triterpene from the fruits of Chaenomeles sinensis
.
Planta Med.
2003;
69
327-31
-
10
Han Y N, Rhee I K.
Changes of tissue factor activity on inflammatory stimulus and aging in rat.
Arch Pharm Res.
1998;
21
549-54
-
11
Cho J Y, Park J S, Baik K U, Lee J G, Kim H P, Yoo E S. et al .
Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritis.
Pharmacol Res.
2004;
49
423-31
-
12
Sommeijer D W, Hansen H R, Vano R, Hamulyak K, Vanz A P, Meesters E. et al .
Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes.
J Thromb Haemost.
2005;
3
1168-71
-
13
Gorlach A.
Redox regulation of the coagulation cascade.
Antioxid Redox Signal.
2005;
7
1398-404
-
14
Miller D L, Welty-Wolf K, Carraway M S, Ezban M, Ghio A, Suliman H. et al .
Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.
Am J Respir Cell Mol Biol.
2002;
26
650-8
-
15
Carmeliet P, Moons L, Dewerchin M, Mackman N, Luther T, Breier G. et al .
Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.
Ann N Y Acad Sci.
1997;
811
191-206
-
16
Yim J S, Kim Y S, Moon S K, Cho K H, Bae H S, Kim J J. et al .
Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora.
Biol Pharm Bull.
2004;
27
1580-3
-
17
Cho J Y, Park J, Yoo E S, Baik K U, Jung J H, Lee J. et al .
Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-alpha production in murine macrophage-like cells.
Planta Med.
1998;
64
594-7
-
18
Cho J Y, Baik K U, Jung J H, Park M H.
In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, from Saussurea lappa
.
Eur J Pharmacol.
2000;
398
399-407
-
19
Lindmark E, Siegbahn A.
Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin.
Thromb Res.
2002;
108
77-84
-
20
Camera M, Giesen P L, Fallon J, Aufiero B M, Taubman M, Tremoli E. et al .
Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells.
Arterioscler Thromb Vasc Biol.
1999;
19
531-7
Jae Youl Cho, PhD
School of Biotechnology and Bioengineering
Kangwon National University
192-1 Hyja-2-dong
Chuncheon
Kangwon-do 200-701
South Korea
Fax: +82-33-253-6560
Email: jaecho@kangwon.ac.kr